News

The company will be managed by its existing executive management team on an interim basis. Michael Taglich, chairman of the board of Scolr Pharma, said: “On behalf of

The Uscom 1A offers real-time, beat-to-beat measurements of 20 parameters of cardiovascular function including cardiac output, stroke volume and systemic vascular resistance with additional parameters such as cardiac

These latest EU patents follow on the heels of a major clinical patent that was recently awarded in the US for targeted gene delivery in vivo. Together these

Under the agreement, Roche will develop an assay kit utilizing Fujirebio Diagnostics’s HE4 test on its automated immunoassay analyzers. The HE4 test was developed by Fujirebio Diagnostics to

According to the company, the Proceed ventral patch (PVP) device is the first and only umbilical hernia repair device featuring lighter-weight mesh and exclusive, absorbable deployment technology. It

The company expects to record a charge of approximately $1.9 million in the fourth quarter of 2008 related to this workforce reduction. Separately, Jazz Pharmaceuticals also said that

Mr Legault will succeed Michael Atieh who will be stepping down from the CFO position on December 29, 2008, pending his previously announced retirement which will now occur

Pioneer attracted new participation from InvestMichigan! Growth Capital Fund. Previous investors Pharos Capital Group, Highlander Partners, Hopewell Ventures and River Cities Capital Funds also participated in the round.

Dr An comes to Epitomics from Merck Research Laboratories, where he was director of biologics research. He has over 12 years of experience in drug discovery and development